Day: April 23, 2021

De nouvelles analyses des données relatives à Dupixent®(dupilumab) confortent son profil de sécurité et d’efficacité à long terme chez les patients atteints de dermatite atopique, dès l’âge de 6 ans        Près de 30 présentations de données obtenues dans le cadre d’essais cliniques et en vie réelle aux congrès de l’AAD et de l’ESPD, dont des données de l’impact de Dupixent sur les indicateurs de la dermatite atopique modérée à sévère non contrôlée. Congrès de l’AAD : présentation de dernière heure des données de phase II du rilzabrutinib, un médicament expérimental pour le traitement du pemphigus vulgaire – une maladie auto-immune rare et invalidante.PARIS – Le 23 avril 2021 – De nouvelles analyses des données des essais cliniques consacrés à Dupixent® (dupilumab) ont permis de faire ressortir une réduction de l’incidence des infections...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OTTAWA, April 23, 2021 (GLOBE NEWSWIRE) — Leonovus Inc. (TSXV:LTV) (the “Company” or “Leonovus”), announces that it has amended certain terms of its public offering, that was previously announced on March 29, 2021 (the “Offering”). Pursuant to the amended terms, the Offering of units of the Company (the “Units”) will be conducted at a price of $0.56 per Unit (the “Offering Price”) for minimum gross proceeds of $2,500,000 and maximum gross proceeds of $4,000,000. Each Unit shall be comprised of one common share of the Company (a “Common Share”) and one Common Share purchase warrant of the Company (a “Warrant”). Each Warrant is exercisable into one Common...

Detailed results from Phase 2b study of roflumilast foam in scalp and body psoriasis featured in late-breaking oral presentation Data demonstrate roflumilast foam was well-tolerated and improved scalp and body psoriasis as early as two weeks after treatment initiation Four additional posters feature data that support roflumilast foam for the treatment of seborrheic dermatitis and roflumilast cream for mild-to- severe chronic plaque psoriasisWESTLAKE VILLAGE, Calif., April 23, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced the presentation of new data demonstrating the safety and efficacy of roflumilast...

Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy assessments showed a clinically meaningful and sustained improvement in sweat severity through the 48 weeks of treatment Data presented today in a late-breaking oral presentation at AAD VMX 2021 Management to host an investor call today at 12:00 p.m. EDT BOULDER, Colo., April 23, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced results from its Phase 3 open-label, long-term safety study (“ARGYLE” or “LTSS”), which were also presented today in a late-breaking oral presentation at the American Academy...

ISELIN, N.J., April 23, 2021 (GLOBE NEWSWIRE) — Middlesex Water Company (NASDAQ:MSEX) announced today that its Board of Directors has declared a cash dividend of $0.2725 per share on its common stock payable on June 1, 2021 to holders of record as of May 14, 2021. Middlesex Water has paid cash dividends in varying amounts continually since 1912 and has increased its annual dividend rate for 48 consecutive years. The Company began mailing its Annual Meeting materials on April 12, 2021. Due to health concerns surrounding COVID-19 and to support the health and well-being of participants, Middlesex Water Company’s Annual Meeting of Shareholders will be held on May 25, 2021 at 11:00 a.m. EDT via webcast only. Shareholders will be able to participate in the Annual Meeting by visiting http://www.virtualshareholdermeeting.com/MSEX2021 and...

Vancouver, British Columbia, April 23, 2021 (GLOBE NEWSWIRE) — St. James Gold Corp. (TSX-V: LORD) (OTC: LRDJF)(FSE: BVU3) the “Company” is pleased to announce the appointment of its technical advisory team and formation of a technical committee in anticipation of upcoming gold exploration activities on its option on the Florin Gold Project in the Yukon Territory, Canada and its projects in Quinn Lake and Grub Line located in Newfoundland and Labrador, Canada. In total, these two team members alongside our VP of Exploration, Stewart Jackson and the three members from the Florin Gold Project’s technical team, bring over 100 years of exploration and mining experience. These appointments represent a key advancement to overseeing drill budgeting in the Yukon and Newfoundland as the Company prepares for an active 2021 exploration season. The...

ATLANTA, April 23, 2021 (GLOBE NEWSWIRE) — Sage (FTSE: SGE), the market leader in cloud business management solutions, today shared the financial management efficiencies and insights Whole Family Health Center gained by moving its financial software to the cloud. Migrating from Sage 50 to Sage Intacct – just as the COVID-19 pandemic struck in March 2020 – Whole Family’s finance team has been able to absorb new workloads and demands triggered by the pandemic. Overall accounting efficiency has leapt at Whole Family, a nonprofit healthcare provider on Florida’s Treasure Coast, as it has eliminated nearly 50 hours of manual accounting work each month and reduced its monthly close time by 73%. Improved efficiency and capacity have been critical as Whole Family added 10 new providers during COVID-19 at clinics in Fort Pierce and Vero...

UPDATE includes attachment, which can be downloaded from www.newsweb.no. Anne Grethe Dalane, Board Member of PGS has today April 23, 2021 bought 30 000 shares in PGS at a price of NOK 5.03 per share. Following the transaction, Anne Grethe Dalane owns 48 000 shares in PGS. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act AttachmentSkjema for melding PGS aksjer KRT-1500 Dalane

Meðfylgjandi eru endanleg dagskrá og tillögur fyrir aðalfund félagsins, sem verður haldinn kl. 16:00 mánudaginn 26. apríl 2021. Fundurinn fer alfarið fram rafrænt þar sem aðstæður leyfa það ekki að taka á móti hluthöfum. Dagskrá aðalfundar er óbreytt frá fyrri tilkynningu félagsins 30. mars 2021 þar sem engar kröfur eða ályktanir bárust innan tilskilins frests frá hluthöfum um tiltekin mál. Önnur fundargögn en þau sem fylgja með, má finna á heimasíðu félagsins á slóðinni: http://eik.is/hluthafar Hluthafar eða umboðsmenn hluthafa sem hyggjast taka þátt í fundinum eru minntir á að skrá sig tímanlega á heimasíðunni www.smartagm.com og ekki seinna en kl. 16:00 sunnudaginn 25. apríl 2021. Aðstoð við skráningu á aðalfundinn er hægt að fá á netfanginu: stjornun@eik.is. Hluthafar sem hafa hug á að taka til máls á fundinum skulu upplýsa um það...

SAN ANTONIO, April 23, 2021 (GLOBE NEWSWIRE) — Rackspace Technology, Inc. (NASDAQ: RXT) hat heute bekanntgegeben, dass das Unternehmen seine Geschäftsergebnisse für das erste Quartal 2021 am Montag, den 10. Mai 2021, nach Börsenschluss veröffentlichen wird. Zudem werden Kevin Jones, Chief Executive Officer, und Amar Maletira, Chief Financial Officer, am Tag der Bekanntgabe (10. Mai 2021) um 17:00 Uhr ET eine Telefonkonferenz zur Besprechung der Geschäftsergebnisse des Unternehmens abhalten. Interessierte können unter 1-877-300-8521 (im Inland) oder 1-412-317-6026 (im Ausland) live an der Telefonkonferenz teilnehmen (nach Eingabe der Nummer, die Telefonkonferenz zu den Erträgen von Rackspace Technology im ersten Quartal 2021 anfordern). Die Teilnehmer werden gebeten, sich einige Minuten vor der Konferenz einzuwählen, um sich für...